GREGORY B. BROWN - 20 Jun 2024 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Director
Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
20 Jun 2024
Net transactions value
$0
Form type
4
Filing time
21 Jun 2024, 13:51:01 UTC
Previous filing
11 Jan 2024
Next filing
13 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AQST Common Stock 75,085 20 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQST Stock Option (Right to Purchase) Award $0 +38,000 $0.000000 38,000 20 Jun 2024 Common Stock 38,000 $2.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date.